ArticleCancer medicine2023

The NRF2 antagonist ML385 inhibits PI3K-mTOR signaling and growth of lung squamous cell carcinoma cells.

Lili Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.